Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqGM - Nasdaq Real Time Price USD

Tevogen Bio Holdings Inc. (TVGN)

Compare
1.0900
+0.0100
+(0.93%)
At close: April 1 at 4:00:01 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Operating Expense
39,581.4920
2,273.9700
953.0830
4,618.4620
Operating Income
-39,581.4920
-2,273.9700
-953.0830
-4,618.4620
Net Non Operating Interest Income Expense
464.5570
-256.0310
--
-598.5020
Other Income Expense
91,672.2300
2,462.6760
5,361.4440
-10,379.8340
Pretax Income
52,555.2950
-67.3250
4,408.3610
-15,596.7980
Net Income Common Stockholders
55,913.6020
-67.3250
4,408.3610
-15,596.7980
Diluted NI Available to Com Stockholders
55,913.6020
-67.3250
4,408.3610
-15,596.7980
Basic EPS
0.35
-0.00
0.04
-0.13
Diluted EPS
0.35
-0.00
0.04
-0.13
Basic Average Shares
170,646.8640
165,421.0840
119,999.9890
119,999.9890
Diluted Average Shares
170,646.8640
165,421.0840
119,999.9890
119,999.9890
Total Operating Income as Reported
--
--
-13,724.0640
-4,618.4620
Total Expenses
39,581.4920
2,273.9700
953.0830
4,618.4620
Net Income from Continuing & Discontinued Operation
52,495.2950
-67.3250
4,408.3610
-15,596.7980
Normalized Income
56,468.4523
-2,530.0010
172.8202
-15,596.7980
Interest Expense
-464.5570
256.0310
--
598.5020
Net Interest Income
464.5570
-256.0310
--
-598.5020
EBIT
52,090.7380
188.7060
4,408.3610
-14,998.2960
EBITDA
52,090.7380
188.7060
4,408.3610
-14,988.9190
Reconciled Depreciation
--
--
230.8230
9.3770
Net Income from Continuing Operation Net Minority Interest
52,495.2950
-67.3250
4,408.3610
-15,596.7980
Total Unusual Items Excluding Goodwill
-5,029.3130
2,462.6760
5,361.4440
--
Total Unusual Items
-5,029.3130
2,462.6760
5,361.4440
--
Normalized EBITDA
57,120.0510
-2,273.9700
-953.0830
-14,988.9190
Tax Rate for Calcs
0.0002
--
0.0002
--
Tax Effect of Unusual Items
-1,056.1557
--
1,125.9032
--
12/31/2021 - 1/5/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

NKGN NKGen Biotech, Inc.
0.1913
+6.28%
 
SPRC SciSparc Ltd.
0.2809
-5.74%
 
ZVSA ZyVersa Therapeutics, Inc.
0.5875
-6.54%
 
CDIO Cardio Diagnostics Holdings, Inc.
0.3600
+9.09%
 
REVB Revelation Biosciences, Inc.
2.6000
-1.14%
 
ONCO Onconetix, Inc.
0.0757
-2.95%
 
PXMD PaxMedica, Inc.
0.0002
0.00%
 
BDRX Biodexa Pharmaceuticals Plc
1.2000
-9.09%
 
VRAX Virax Biolabs Group Limited
1.0979
-3.69%
 
ENSC Ensysce Biosciences, Inc.
2.5000
-2.34%